Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Früh, Panje, Reck, Blackhall, Califano, Cappuzzo, Besse, Novello, Garrido, Felip, O'Brien, Paz Ares, de Marinis, Westeel, De Ruysscher, Putora (2020) Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts Lung Cancer (IF: 5.3) 146 6-11Links
http://www.ncbi.nlm.nih.gov/pubmed/32485661http://dx.doi.org/10.1016/j.lungcan.2020.03.024
